The authors identified a small set of genes preferentially expressed in MDS (e.g., DLK1, TEC, and ITPR1) or AML (e.g., genes encoding solute carrier (SLC) family members, opioid receptor delta 1 (OPRD1) and leptin receptor (LEPR)). This evidence concerns the gene LEPR and myelodysplastic syndrome.